NAV3 is also a target for exosomal miR-21-3p in promoting CDDP resistance [31], suggesting an important role of EXs in cell–cell communication in the development of drug resistance in a plethora of cancers, including OVCA. The gene discussed is NAV3; the disease is cancer.